News & Events

  • Nydiaris Hernandez-Santos, PhD Receives Burroughs Wellcome Fund Postdoctoral Grant

    Posted: July 2016
    Bruce S. Klein, MD
    Bruce S. Klein, MD

    Nydiaris Hernandez-Santos, PhD, Postdoctoral Fellow in the laboratory of Bruce Klein, MD, has been awarded a $60,000, 3-year Postdoctoral Enrichment Program award from the Burroughs Wellcome Fund. This grant is designed to support the career development activities for underrepresented minority postdoctoral fellows whose training and professional development are guided by mentors committed to helping them advance to stellar careers in biomedical or medical research. Her project, entitled "Role of airway epithelial cells in host defense against pulmonary fungal pathogens," will allow her to test the hypothesis that airway epithelial cells underpin host resistance to fungi.

     
  • Research Associate Receives Postdoctoral Fellowship Award from the AHA

    Posted: July 2016
    Bruce S. Klein, MD
    Bruce S. Klein, MD
    Huafeng Wang, PhD
    Huafeng Wang, PhD

    Congratulations to Huafeng Wang, PhD, who was recently awarded a Postdoctoral Fellowship from the American Heart Association (AHA) of $110,300 over 2 years. For his project, "New Adjuvants for the Prevention of Cardiovascular Fungal Infections," Dr. Wang, under the mentorship of Marcel Wüethrich, PhD, and Bruce Klein, MD, will identify fungal cell wall ligand(s) that are recognized by Dectin-2 (a C-type lectin receptor) and test their adjuvancy with a safe subunit fungal vaccine. Findings from this project will ultimately advance methods of prevention among cardiovascular patients that are at risk of fungal infection.

     
  • James Gern, MD, Receives NIH Supplement

    Posted: July 2016
    James E. Gern, MD
    James E. Gern, MD

    Congratulations to James Gern, MD, who recently was awarded a supplement to his U19 grant award from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH-NIAID) Asthma and Allergic Diseases Cooperative Research Centers (AADCRC). The supplement, in the amount of $143,009, is titled, "A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV-16) Inoculum in Healthy Volunteers," and will help determine the dose of reverse genetics human rhinovirus 16 (RG-RV16) needed to produce moderate colds in most seronegative individuals, in order lead to testing of new antiviral agents.

     
  • Nydiaris Hernandez-Santos, PhD, Receives NIH Diversity Supplement Support

    Posted: July 2016
    Bruce S. Klein, MD
    Bruce S. Klein, MD

    Congratulations to Bruce Klein, MD, and Postdoctoral Fellow Nydiaris Hernandez-Santos, PhD, who have been awarded a Research Supplement to Promote Diversity in Health-Related Research Program from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH-NIAID) in the amount of $173,655. This supplement, as part of Dr. Klein's NIH-NIAID R01 Parent Award entitled, "Molecular pathogenesis of Blastomycosis," provides 2 years of support for Dr. Hernandez-Santos' research.

     
  • Daniel Jackson, MD, Part of Consortium Awarded NIH U01 Grant

    Posted: July 2016
    Daniel J. Jackson, MD
    Daniel J. Jackson, MD

    Researchers from the University of Arizona Health Sciences and seven other institutions, including the UW Department of Pediatrics, were recently awarded a 5-year, $27 million cooperative agreement grant from the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH-NHLBI), for their project entitled, "Oral Bacterial Extracts (ORBEX): Primary Prevention of Asthma and Wheezing in Children." Daniel Jackson, MD, will serve as Site Principal Investigator for the UW's subcontract of over $2 million. For their part, along with Co-Investigator Robert Lemanske, MD, UW Investigators will enroll infants in a clinical study that will evaluate the use of Bronchovaxom (an extract of different bacterial species frequently responsible for respiratory infections) to prevent the development of wheezing in infants at high risk for asthma. More about this project can be found here.

     
  • Bikash Pattnaik, PhD, Named M.D. Matthews/Retina Research Foundation Research Professor

    Posted: July 2016
    Bikash R. Pattnaik, PhD
    Bikash R. Pattnaik, PhD

    Congratulations to Bikash Pattnaik, PhD, who was recently named as the Retina Research Foundation M.D. Matthews Research Professor for 2016-2019. This professorship, with support from the McPherson Eye Research Institute, provides $50,000 annually in support of Dr. Pattnaik's project titled, "Vision loss due to ion-channelopathy."

     
  • Jennifer Rehm, MD, Awarded AHEAD Grant from ICTR

    Posted: July 2016
    Brittany J. Allen, MD
    Brittany J. Allen, MD
    Jennifer L. Rehm, MD
    Jennifer L. Rehm, MD

    Jennifer Rehm, MD, Principal Investigator, and Brittany Allen, MD, Co-Investigator, were recently awarded a $10,000 pilot grant from the Advancing Health Equity and Diversity (AHEAD) program, of the UW Institute for Clinical and Translational Research (ICTR). In their one-year project, titled "Wisconsin Survey of Trans Youth: An Assessment of Resources and Needs," they will survey and conduct focus groups with transgender and gender nonconforming youth (TGNC) to identify community needs and barriers to accessing resources that will serve as an effective platform for future advocacy and resource development.

     
  • Krishanu Saha, PhD, Christian Capitini, MD, and David Beebe, PhD, Awarded NSF Grant

    Posted: July 2016
    Christian M. Capitini, MD
    Christian M. Capitini, MD

    Congratulations to Krishanu Saha, Principal Investigator, UW Department of Biomedical Engineering, and Co-Principal Investigators Christian Capitini and David Beebe (Department of Biomedical Engineering), on funding of their National Science Foundation (NSF) proposal entitled, "EAGER BIOMANUFACTURING: A Microscale Testbed to Assay and Manufacture CAR T-Cell Immunotherapies." This 2-year award, in the amount of $300,000, will utilize genetically-engineered human T-cells that express chimeric antigen receptors (CARs) to target cancer associated antigens. The investigators propose to develop a flexible, cost-effective, and scalable microscale co-culture system to isolate functional gene-edited CAR T-cells, expand the fraction, and assess in vivo functionality.

     
  • Daniel Sklansky, MD, Selected for APPD LEAD Program

    Posted: July 2016
    Daniel J. Sklansky, MD
    Daniel J. Sklansky, MD

    Dr. Daniel Sklansky has been selected to participate in a nationally-recognized leadership development program: the Association of Pediatric Program Director’s Leadership in Educational Academic Development (APPD LEAD). APPD LEAD is a program that provides a unique opportunity for pediatric academic leaders in medical education to engage and learn from seasoned program directors, pediatric educators, and other national leaders in pediatrics. The LEAD curriculum focuses on organizational leadership, competency-based curriculum development, faculty development, residency and fellowship program administration, scholarship and career development. The curriculum is paced over three educational conferences, with additional group activities, readings and project work expected between conferences. Dr. Sklansky is an Associate Residency Program Director and has interests in medical education, the development of resident autonomy, and self-determination theory.

     
  • Norman Fost, MD, MPH, to Receive MacLean Center for Clinical Medical Ethics Prize

    Posted: July 2016
    Norman C. Fost, MD, MPH
    Norman C. Fost, MD, MPH

    Congratulations to Dr. Norman Fost, who has been chosen to receive the 2016 MacLean Center Prize in Clinical Ethics and Health Outcomes. The award, given by the MacLean Center for Clinical Medical Ethics, is the largest prize in bioethics and clinical ethics, and celebrates individuals who have made transformative contributions to the field of clinical medical ethics through scholarship, practice, leadership, and policy development. The award will be presented to Dr. Fost at the MacLean Center's annual conference, hosted November 11th and 12th, 2016 at the University of Chicago Law School.